India recorded nearly 350,000 cases during the third wave, however, deaths were muted, unlike in the US and Europe
Subsequent waves reflect lower restrictions, compared to initial lockdown
Significantly, on 21 out of 23 days of March so far, the city has logged zero COVID-19 deaths
Masks, social distancing norms to continue; States and UTs allowd to issue standard operating procedures (SoPs) for containment measures, vaccination
As many as 23,238 samples were tested in the last 24 hours
WHO cautioned that with many countries dropping widespread testing programs, many infections are likely being missed and new case numbers should be interpreted cautiously
India has so far administered 1,818,915,234 vaccine doses. That is 4228.78 per cent of its total caseload, and 129.67 per cent of its population
With 1,778 new coronavirus infections, India's total tally of Covid-19 cases rose to 430,12,749, while the number of active cases declined by over 800 to 23,087, according to government data.
The global coronavirus caseload has topped 473.9 million, while the deaths have surged to more than 6.09 million and vaccinations to over 10.81 billion, according to the Johns Hopkins University.
Witnessing a COVID surge, China on Tuesday reported 2,591 locally transmitted COVID-19 cases, the National Health Commission said Wednesday.
New Zealand will remove many of its COVID-19 pandemic mandates over the next two weeks as an outbreak of the omicron variant begins to wane.
The Supreme Court reserved its order on a PIL seeking public disclosure of COVID-19 vaccine clinical trial data and post-vaccination data
The state had reported 123 COVID-19 cases and one death on Monday.
The Covid vaccination pace has slowed down relatively as most of the target beneficiaries are already covered, the Centre informed Parliament on Tuesday
Bharat Biotech may have gained immense popularity with its COVID-19 vaccine Covaxin, but the firm's founder and chairman Krishna Ella says science remains his passion
As of March 20, the seven-day moving average of US Covid-19 cases was 27,786, down 17.6% from a week earlier.
The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday. The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply. The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16. The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine ...
Previous studies have shown that the human pancreas can also be a target of SARS-CoV-2, the virus causing Covid
India has so far administered 1,815,601,944 vaccine doses. That is 4221.25 per cent of its total caseload, and 129.44 per cent of its population
India crossed 750 mn vaccinations milestone on September 7, 2021, and achieved a milestone of 1 bn vaccinations on October 21, 2021